Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 03 tags : Drug save search
OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
OSUR | $5.25 0.0% 520K
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: -5.59%
oracollect clearance drug device food
Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting
Published: 2022-11-03 (Crawled : 14:00) - biospace.com/
PRTA 4 | $20.57 -2.05% -1.94% 570K
|
Health Technology
|
| O: -1.99%
H: 0.55%
C: -1.64%
drug candidate meeting study
Equillium Announces Presentation at the 6th Annual Dermatology Drug Development Summit
Published: 2022-11-03 (Crawled : 13:00) - biospace.com/
EQ | $1.73 -3.35% -1.13% 74K
|
Health Technology
|
| O: -2.31%
H: 1.78%
C: 1.18%
drug presentation
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
CELZ | $4.81 -3.7% -1.73% 14K
|
|
| O: 19.85%
H: 41.67%
C: 4.17%
treatment fda clearance drug application technology diabetes therapy
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.